| Serial Number | 98831068 |
| Word Mark | HERANOVA |
| Filing Date | Thursday, October 31, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 8, 2025 |
| Goods and Services | Medical devices, namely, surgical and nonsurgical devices for treating endometriosis, infertility, and gynecological diseases and disorders. |
| Goods and Services | Providing medical information in the field of gynecology; medical information services in the gynecological field; medical testing services for diagnostic purposes in the field of gynecology, namely, testing services for detecting endometritis, a woman's personalized embryo implantation time, and/or Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility; medical diagnostic services for gynecological diseases and disorders, namely, for detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes; medical assessment services, namely, health assessment of a patient's remaining childbearing years based on patient-specific health information. |
| Goods and Services | Medical diagnostic assays for testing for the presence of biomarkers in blood or bodily fluids for diagnosing gynecological diseases, namely endometriosis; Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time and for determining a patient's personalized treatment plan, as well as the composition of microbiome, including presence of normal lactobacillus and targeted pathogenic bacteria, namely, Escherichia, Klebsiella, Enterococcus, Streptococcus, Mycoplasma, Chlamydia, Ureaplasma, Neisseria, Staphylococcus, and Gardnerella; Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; for bacterial, fungal and resistance markers for determining a personalized treatment plan; Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosing gynecological diseases, namely, primary ovarian insufficiency; Pharmaceuticals, namely, therapeutic drugs for treating endometriosis, infertility, and gynecological diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Heranova Lifesciences Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, MA 01803 US |
| Party Name | Heranova Lifesciences Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, MA 01803 US |
| Event Date | Event Description |
| Thursday, October 31, 2024 | NEW APPLICATION ENTERED |
| Sunday, May 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 5, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 8, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 8, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, May 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 2, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 8, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 8, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 2, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 2, 2026 | TEAS STATEMENT OF USE RECEIVED |